Victory Capital Management Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Victory Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$0.28 - $1.16 $1,238 - $5,130	4,423 Added 2.5%	181,203 $59,000
Q1 2024 May 03, 2024	SELL	$1.06 - $1.67 $1,468 - $2,312	-1,385 Reduced 0.78%	176,780 $205,000
Q4 2023 Feb 05, 2024	BUY	$1.26 - $1.79 $49,355 - $70,116	39,171 Added 28.18%	178,165 $301,000
Q3 2023 Nov 06, 2023	BUY	$1.61 - $2.54 $3,013 - $4,754	1,872 Added 1.37%	138,994 $251,000
Q2 2023 Jul 27, 2023	BUY	$1.14 - $1.95 $28,271 - $48,360	24,800 Added 22.08%	137,122 $255,000
Q1 2023 May 02, 2023	BUY	$1.2 - $2.19 $3,799 - $6,933	3,166 Added 2.9%	112,322 $149,000
Q4 2022 Feb 10, 2023	BUY	$1.63 - $3.52 $1,602 - $3,460	983 Added 0.91%	109,156 $184,000
Q4 2022 Feb 09, 2023	BUY	$1.63 - $3.52 $31,814 - $68,703	19,518 Added 22.02%	108,173 $182,000
Q3 2022 Nov 02, 2022	SELL	$0.73 - $3.74 $51,404 - $263,359	-70,417 Reduced 44.27%	88,655 $277,000
Q2 2022 Aug 01, 2022	SELL	$2.2 - $4.2 $1,597 - $3,049	-726 Reduced 0.45%	159,072 $379,000
Q1 2022 May 04, 2022	SELL	$2.83 - $8.69 $506,643 - $1.56 Million	-179,026 Reduced 52.84%	159,798 $463,000
Q4 2021 Feb 07, 2022	BUY	$8.31 - $14.92 $2.82 Million - $5.06 Million	338,824 New	338,824 $2.82 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.